Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
65°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
Photos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Best of 2023
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
2seventy bio, Inc. - Common Stock
(NQ:
TSVT
)
4.510
+0.110 (+2.50%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about 2seventy bio, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
2seventy Bio Shares Jump On Positive Data From Bristol Myers-Partnered Cancer Immunotherapy
August 10, 2022
Via
Benzinga
2seventy bio Reports Second Quarter Financial Results and Recent Operational Progress
August 10, 2022
From
2seventy bio, Inc.
Via
Business Wire
Bristol Myers Squibb and 2seventy bio Announce Topline Results from KarMMa-3 Trial Showing Abecma (idecabtagene vicleucel) Significantly Improves Progression-Free Survival Versus Standard Regimens in Relapsed and Refractory Multiple Myeloma
August 10, 2022
From
Bristol Myers Squibb
Via
Business Wire
2seventy bio to Participate in Upcoming Investor Conferences
August 03, 2022
From
2seventy bio, Inc.
Via
Business Wire
The Top E-Commerce Company to Buy for Summer 2022
June 17, 2022
There's definitely a chance that struggling RealReal simply goes bankrupt, but its network effects could make it a buyout target.
Via
InvestorPlace
The 5 Top Profit & Protection Stocks to Buy for 2022
June 17, 2022
It's important to know which quantitative factors make a stock worthwhile. These five have the attributes needed for success.
Via
InvestorPlace
2seventy bio to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference
June 06, 2022
From
2seventy bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
June 14, 2022
On Tuesday, 951 companies hit new 52-week lows.
Via
Benzinga
2seventy bio Reports First Quarter Financial Results and Recent Operational Progress
May 12, 2022
From
2seventy bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2022
May 02, 2022
Upgrades
Via
Benzinga
2seventy bio Presents New Preclinical Data on bbT369, an Investigational Dual-Targeting Gene-Edited CAR T Cell Therapy, at the AACR Annual Meeting
April 08, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio to Participate in CG Horizons in Oncology Virtual Conference
April 07, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Operational Progress
March 22, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Secures $170 Million in Private Placement Equity Financing
March 16, 2022
From
2seventy bio, Inc.
Via
Business Wire
Stocks That Hit 52-Week Lows On Tuesday
March 15, 2022
During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 08, 2022
Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
March 04, 2022
On Friday, 368 stocks hit new 52-week lows. Interesting Points From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...
Via
Benzinga
2seventy bio Announces Key Management Appointments
February 14, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio to Participate in Upcoming Healthcare Conferences
February 14, 2022
From
2seventy bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For February 10, 2022
February 10, 2022
Upgrades According to Gordon Haskett, the prior rating for Williams-Sonoma Inc (NYSE:WSM) was changed from Hold to Accumulate. Williams-Sonoma earned $3.32 in the third quarter,...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 31, 2022
Gainers Oncternal Therapeutics (NASDAQ:ONCT
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 13, 2022
Gainers iSpecimen (NASDAQ:ISPC) shares rose 19.8% to $8.18 during Thursday's pre-market session. The market value of their outstanding shares is at $71.4 million. VYNE...
Via
Benzinga
Bristol Myers, 2seventy Pull Plug On Multiple Myeloma CAR-T As Abecma Sales Gain Momentum
January 11, 2022
2seventy bio Inc's (NASDAQ: TSVT) anti-BCMA CAR-T got axed as part of a corporate update. The treatment was under development in collaboration with Bristol...
Via
Benzinga
2seventy bio Shares Key Milestones and Business Updates for 2022
January 11, 2022
From
2seventy bio, Inc.
Via
Business Wire
2seventy bio Announces Expanded Collaboration Agreement With Novo Nordisk to Continue Development of in vivo Gene Editing Approach
January 06, 2022
From
2seventy bio, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022
January 06, 2022
Upgrades For Canada Goose Holdings Inc (NYSE:
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
January 05, 2022
Before 10 am on Wednesday, 99 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: Sea (NYSE:SE) was the largest firm by market cap to set a...
Via
Benzinga
3 Best Performing Healthcare IPOs in 2021
December 28, 2021
Healthcare IPOs, 2seventy bio, Inc., Regencell Bioscience Holdings Limited, and Biofrontera Inc. have generated significant returns since their stock market debut and could be ideal additions to one’s...
Via
Talk Markets
2seventy bio Presents Data Across Multiple Cell Therapy Programs at ASH 2021 Annual Meeting
December 13, 2021
From
2seventy bio, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
December 03, 2021
Gainers Celyad Oncology (NASDAQ:CYAD) shares rose 22.75% to $4.37 during Friday's pre-market session. The company's market cap stands at $70.3 million. Biolase (...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.